Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry

被引：11

作者：

Bilton, Diana ^{[1
,2
]}

Caine, Noreen ^{[5
]}

Cunningham, Steve ^{[3
]}

Simmonds, Nicholas J. ^{[1
,2
]}

Cosgriff, Rebecca ^{[5
]}

Carr, Siobhan B. ^{[4
]}

机构：

[1] Royal Brompton & Harefield NHS Fdn Trust, Adult Cyst Fibrosis Ctr, London, England

[2] NHLI Imperial Coll, London, England

[3] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland

[4] Royal Brompton & Harefield NHS Fdn Trust, Dept Paediat Resp Med, London, England

[5] UK Cyst Fibrosis Trust, London, England

来源：

关键词：

D O I：

10.1016/S2213-2600(18)30192-9

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：495 / 496

页数：3